Paul Tudor Jones Kala Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $31,209 - $64,682	-11,912 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $60,274 - $97,082	11,912 New	11,912 $63,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $198,390 - $293,881	-26,452 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.33 - $13.79 $178,028 - $294,719	-21,372 Reduced 44.69%	26,452 $278,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $183,165 - $420,372	47,824 New	47,824 $420,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.